Search results for "TUMOR"

showing 10 items of 6365 documents

Hemostasis in brain tumor surgery using the Aquamantys system

2014

Background: Adequate hemostasis in cranial and spinal tumor surgery is of paramount importance in neurosurgical practice. Generalized ooze bleeding from the surgical walls cavity, coming from neoplastic vessels or nervous tissue, may be problematic. Recent technical advances have dramatically reduced intraoperative complications related to blood loss. Several techniques are usually employed to control hemostasis in tumor surgery, including preoperative embolization, intraoperative hypotension, electrical coagulation, and local application of fibrin sealants or hemostatic matrix, which influence coagulation. Material/Methods: Our aim in this study was to evaluate the efficacy and the safety …

medicine.medical_specialtyRadio WavesBlood Loss SurgicalPreoperative careHemostaticsProduct InvestigationsBlood lossSurgicalPreoperative CaremedicineHumansBrain tumor surgeryHemostasisIntraoperative Caremedicine.diagnostic_testbusiness.industryBrain NeoplasmsSettore MED/27 - Neurochirurgiatumor meningiomaBlood lossMagnetic resonance imagingGeneral MedicineMiddle AgedMagnetic Resonance ImagingSurgeryRadiographyNasal MucosaCoagulationSpinal tumorHemostasisTumor surgeryFemalebusinessMeningiomaFollow-Up Studies
researchProduct

Repeated resection for recurrent intrahepatic cholangiocarcinoma: A retrospective German multicentre study.

2020

Background Tumour recurrence is common after resection of intrahepatic cholangiocarcinoma (ICC). Repeated resection is a potential curative treatment, but outcomes are not well-defined thus far. The aim of this retrospective multicentre cohort study was to show the feasibility and survival of repeated resection of ICC recurrence. Methods Data were collected from 18 German hepato-pancreatico-biliary centres for patients who underwent repeated exploration of recurrent ICC between January 2008 and December 2017. Primary end points were overall (OS) and recurrence-free survival from the day of primary and repeated resection. Results Of 156 patients who underwent repeated exploration for recurre…

medicine.medical_specialtyResectionCholangiocarcinomaCohort Studies03 medical and health sciences0302 clinical medicineMedicineHepatectomyHumansIntrahepatic CholangiocarcinomaRetrospective StudiesHepatologybusiness.industryPrimary resectionRecurrent Intrahepatic Cholangiocarcinoma3. Good healthTumor recurrenceSurgeryTreatment OutcomeBile Duct NeoplasmsMedian timeCurative treatment030220 oncology & carcinogenesis030211 gastroenterology & hepatologyNeoplasm Recurrence LocalbusinessCohort studyLiver international : official journal of the International Association for the Study of the LiverReferences
researchProduct

Adult Coats’ Disease Successfully Managed with the Dexamethasone Intravitreal Implant (Ozurdex®) Combined with Retinal Photocoagulation

2012

Purpose: To report a case of Coats’ disease managed with the dexamethasone intravitreal implant Ozurdex® (Allergan, Inc., Irvine, Calif., USA) combined with retinal photocoagulation. Methods: A 46-year-old female with 20/200 visual acuity was diagnosed with Coats’ disease with secondary retinal vasoproliferative tumor. An initial approach was performed with an intravitreal injection of the sustained-release dexamethasone implant Ozurdex. After reattachment of the retina, the telangiectatic vessels were treated with laser photocoagulation. Results: The patient’s visual acuity improved to 20/25 after the intravitreal Ozurdex. No further recurrences of exudation were evident through the 12-mon…

medicine.medical_specialtyRetinal vasoproliferative tumorVisual acuitychemistry.chemical_compoundRetinal telangiectasislcsh:OphthalmologyOphthalmologymedicineDexamethasone Intravitreal ImplantDexamethasone intravitreal implant (Ozurdex®)Coats' diseaseCoats’ diseaseDexamethasoneRetinabusiness.industryRetinalmedicine.diseaseSurgeryOphthalmologymedicine.anatomical_structurechemistrylcsh:RE1-994Published: March 2012Retinal TelangiectasisImplantmedicine.symptombusinessmedicine.drugCase Reports in Ophthalmology
researchProduct

Uneven modulation of the annexin 1 system in osteoblast-like cells by dexamethasone

2007

AbstractWe tested whether glucocorticoids modulated osteoblast expression of the annexin 1 system, including the ligand and two G-coupled receptors termed formyl-peptide receptor (FPR) and FPR-like-1 (FPRL-1). In Saos-2 cells, rapid up-regulation of FPR mRNA upon cell incubation with dexamethasone (0.01–1μM) was observed, with significant changes as early as 2h and a more marked response at 24h; annexin 1 and FPRL-1 mRNA changes were more subtle. At the protein level, dexamethasone provoked a rapid externalization of annexin 1 (maximal at 2h) followed by delayed time-dependent changes in the cell cytosol. Saos-2 cell surface expression of FPR or FPRL-1 could not be detected, even when dexam…

medicine.medical_specialtySaos-2mRNACellBiophysicsBiologyBiochemistryArticleDexamethasoneAnnexinCell Line TumorInternal medicinemedicineHumansReceptors LipoxinReceptorGlucocorticoidsMolecular BiologyDexamethasoneAnnexin A1OsteoblastsInterleukin-6FPRL-1OsteoblastCell BiologyReceptors Formyl PeptideCell biologyCytosolEndocrinologymedicine.anatomical_structureFPRAnnexin A2medicine.drugAnnexin A1Biochemical and Biophysical Research Communications
researchProduct

Primary Extracranial Meningiomas of the Head and Neck

2021

Meningiomas represent the most common benign histological tumor of the central nervous system. Usually, meningiomas are intracranial, showing a typical dural tail sign on brain MRI with Gadolinium, but occasionally they can infiltrate the skull or be sited extracranially. We present a systematic review of the literature on extracranial meningiomas of the head and neck, along with an emblematic case of primary extracranial meningioma (PEM), which provides further insights into PEM management. A literature search according to the PRISMA statement was conducted from 1979 to June 2021 using PubMed, Web of Science, Google Scholar, and Scopus databases, searching for relevant Mesh terms (primary …

medicine.medical_specialtySciencemedicine.medical_treatmentextracranial meningiomaPsammomatous MeningiomaMalignancyGeneral Biochemistry Genetics and Molecular BiologyMeningiomaplastic surgeryMedicineGrading (tumors)Ecology Evolution Behavior and SystematicsCraniotomySettore MED/27 - Neurochirurgiabusiness.industryBenignityQPaleontologycraniotomyscalp flap reconstructionmedicine.diseasePlastic surgerySkullmedicine.anatomical_structureSpace and Planetary ScienceRadiologySystematic ReviewbusinessLife
researchProduct

Cigarette smoke alters non-neuronal cholinergic system components inducing MUC5AC production in the H292 cell line.

2013

Abstract Cigarette smoke extract (CSE) affects the expression of Choline Acetyl-Transferase (ChAT), muscarinic acetylcholine receptors, and mucin production in bronchial epithelial cells. Mucin 5AC (MUC5AC), muscarinic acetylcholine receptor M3, ChAT expression, acetylcholine levels and acetylcholine binding were measured in a human pulmonary mucoepidermoid carcinoma cell line (H292) stimulated with CSE. We performed ChAT/RNA interference experiments in H292 cells stimulated with CSE to study the role of ChAT/acetylcholine in MUC5AC production. The effects of Hemicholinium-3 (HCh-3) (50 μM) (a potent and selective choline uptake blocker) and Tiotropium bromide (Spiriva ® ) (100 nM), alone o…

medicine.medical_specialtyScopolamine DerivativesBronchiComplex MixturesMucin 5ACCholinergic AntagonistsCholine O-Acetyltransferasechemistry.chemical_compoundAcetylcholine bindingInternal medicineCell Line TumorSmokeparasitic diseasesMuscarinic acetylcholine receptorTobaccomedicineCholineHumansSecretionAlbuterolNeurotransmitter Uptake InhibitorsTiotropium BromideAutocrine signallingSalmeterol XinafoatePharmacologyReceptor Muscarinic M3Epithelial CellsHemicholinium 3respiratory systemCholine acetyltransferaseAcetylcholineBronchodilator AgentsAndrostadienesEndocrinologychemistryCell cultureFluticasoneRNA InterferenceAcetylcholinemedicine.drugEuropean journal of pharmacology
researchProduct

Analyses of odontogenic tumours : the most recent classification proposed by the World Health Organization (2017)

2020

Background The fourth edition of the ‘’WHO Classification of Head and Neck Tumours’’ was published in January 2017 and includes a classification of odontogenic tumours. This review aims to examine the changes made in this new classification in comparison with the previous classification of 2005. Material and Methods An electronic search was conducted in the PubMed, Scopus and Cochrane databases with the keywords “odontogenic tumor”, “WHO classification” and “update”. Studies published from January 2009 to April 2019 with a high level of scientific evidence were included, but studies not published in English, epidemiological studies and studies with a low level of evidence were excluded. Res…

medicine.medical_specialtyScopusMEDLINEOdontogenic TumorsWorld Health OrganizationWorld healthScientific evidenceEpidemiologymedicineHumansMedical physicsGeneral DentistryOral Medicine and Pathologybusiness.industryResearchOdontogenic tumorEvidence-based medicinemedicine.disease:CIENCIAS MÉDICAS [UNESCO]ImmunohistochemistryOdontogenicOtorhinolaryngologyBibliometricsHead and Neck NeoplasmsUNESCO::CIENCIAS MÉDICASSurgerybusiness
researchProduct

Intraoral Schwannomas: presentation of a series of 12 cases

2013

Submitted by Vitor Silverio Rodrigues (vitorsrodrigues@reitoria.unesp.br) on 2014-05-27T11:30:51Z No. of bitstreams: 0Bitstream added on 2014-05-27T14:38:06Z : No. of bitstreams: 1 2-s2.0-84885114651.pdf: 427821 bytes, checksum: 6429b2f0fe956a3fa1d4acd1f8543e13 (MD5) Made available in DSpace on 2014-05-27T11:30:51Z (GMT). No. of bitstreams: 0 Previous issue date: 2013-10-14 Introduction: Schwannomas are benign and not very frequent tumors of the peripheral nerves, derived from the nerve supporting Schwann cells. Study Design: Data were collected on the clinical manifestations (sex, age), location, size and symptonts of the lesions as well as the evolution time and the initial (presumption) …

medicine.medical_specialtySeries (stratigraphy)Floor of mouthOral Medicine and Pathologybusiness.industryResearchOral benign tumorSchwannomasGender distributionMean ageOdontología:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludLesionVery frequentMaximum diameterUNESCO::CIENCIAS MÉDICASmedicineotorhinolaryngologic diseasesRadiologymedicine.symptomPresentation (obstetrics)businessGeneral DentistryNeurilemmoma
researchProduct

Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases.

2011

Receptor activator of NFκB ligand (RANKL), RANK, and osteoprotegerin (OPG) represent the key regulators of bone metabolism both in normal and pathological conditions, including bone metastases. To our knowledge, no previous studies investigated and compared RANK expression in primary tumors and in bone metastases from the same patient. We retrospectively examined RANK expression by immunohistochemistry in 74 bone metastases tissues from solid tumors, mostly breast, colorectal, renal, lung, and prostate cancer. For 40 cases, tissue from the corresponding primary tumor was also analyzed. Sixty-six (89%) of the 74 bone metastases were RANK-positive and, among these, 40 (59.5%) showed more than…

medicine.medical_specialtySettore MED/06 - Oncologia MedicaPhysiologyClinical Biochemistrycolorectal cancerBone NeoplasmsBone remodelingMetastasisProstate cancerbreast cancerOsteoprotegerinInternal medicinemedicineHumansbone metastasibiologyReceptor Activator of Nuclear Factor-kappa Bbusiness.industryMedicine (all)Bone metastasisCell Biologymedicine.diseasePrimary tumorbone metastasis; breast cancer; colorectal cancerImmunohistochemistryEndocrinologyBone Neoplasms; Humans; Immunohistochemistry; Receptor Activator of Nuclear Factor-kappa B; Medicine (all); Physiology; Clinical Biochemistry; Cell BiologyRANKLCancer researchbiology.proteinImmunohistochemistrybusinessJournal of cellular physiology
researchProduct

JC Virus, Helicobacter pylori, and Oesophageal Achalasia: Preliminary Results from a Retrospective Case-Control Study.

2012

medicine.medical_specialtySettore MED/09 - Medicina InternaPhysiologyMEDLINEJC virusAchalasiamedicine.disease_causeGastroenterologyHelicobacter InfectionsTransplant surgeryInternal medicineMedicineHumansRetrospective StudiesJC virus.oesophageal acalasia.case control study.Polyomavirus InfectionsbiologyHelicobacter pyloribusiness.industryGastroenterologyCase-control studyRetrospective cohort studyHepatologyHelicobacter pyloribiology.organism_classificationmedicine.diseaseJC VirusEsophageal AchalasiaTumor Virus Infectionsbusiness
researchProduct